Literature DB >> 17166723

Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.

Ronald Palin1, Anton Bom, John K Clark, Louise Evans, Helen Feilden, Andrea K Houghton, Philip S Jones, Brian Montgomery, Mark A Weston, Grant Wishart.   

Abstract

A series of 3-phenoxypropyl piperidine benzimidazol-2-one analogues have been discovered as novel NOP receptor agonists. Structure-activity relationships have been explored via N-3 substitution of the benzimidazol-2-one with a range of functionality. The N-methyl acetamide derivative (+)-7f was found to be a high-affinity, potent NOP agonist with greater than 100-fold selectivity over the MOP receptor. Furthermore (+)-7f was shown to be both antinociceptive and sedative when administered iv to rodents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166723     DOI: 10.1016/j.bmc.2006.11.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.

Authors:  Nurulain T Zaveri; Faming Jiang; Cris Olsen; Willma E Polgar; Lawrence Toll
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

2.  Synthesis and antibacterial activities of 1-alkyl-3-methacryloyl (acryloyl) of benzimidazolone (thione) derivatives.

Authors:  Shaopeng Wei; Wenjun Wu; Zhiqin Ji
Journal:  Int J Mol Sci       Date:  2012-04-16       Impact factor: 6.208

3.  Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.

Authors:  Pankaj R Daga; Willma E Polgar; Nurulain T Zaveri
Journal:  J Chem Inf Model       Date:  2014-09-17       Impact factor: 4.956

4.  Synthesis of 1-isopropyl-3-acyl-5-methyl-benzimidazolone derivatives and their antimicrobial activity.

Authors:  Nan Xu; Chunnan Yang; Xinqi Gan; Shaopeng Wei; Zhiqin Ji
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.